Century Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Century Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Century Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 82.1M shares, a 38.5% increase year-over-year.
  • Century Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 59.3M shares, a 2.7% increase from 2022.
  • Century Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 57.8M shares, a 78.3% increase from 2021.
  • Century Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 32.4M shares, a 333% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 82.1M +22.8M +38.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 62.3M +3.69M +6.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 59.3M +1.56M +2.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 59.4M +1.47M +2.54% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 59.3M +1.57M +2.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 58.6M +1.56M +2.73% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 57.8M +25.4M +78.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 58M +3.5M +6.43% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 57.7M +45.6M +379% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 57.1M +49.4M +643% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 32.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 54.5M +47M +628% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 12M +4.56M +61% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 7.68M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 7.48M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 7.48M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.